Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition– PCI (CHAMPION PCI — Presented at AHA 2009)

Сangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition–PLATFORM (CHAMPION PLATFORM — Presented at AHA 2009)

Rate Control Efficacy in Permanent Atrial Fibrillation: A Comparison Between Lenient Versus Strict Rate Control II (RACE II)

TReprostinil Sodium Inhalation Used in the Management of Pulmonary Arterial Hypertension (TRIUMPH)

Surgical Treatments for Ischemic Heart Failure Hypothesis 2 (STICH)

Diuretic Optimization Strategies Evaluation in Acute Heart Failure (DOSE)

Atorvastatin Therapy: Effects on Reduction of Macrophage Activity (ATHEROMA)

Sibutramine Cardiovascular Morbidity/Mortality Outcomes in Overweight or Obese Subjects at Risk of a Cardiovascular Event (SCOUT)

A Randomized Clinical Trial of Three Doses of a Long-Acting Oral Direct Factor Xa Inhibitor Betrixaban in Patients With Atrial Fibrillation (EXPLORE-Xa)

Anti-Xa Therapy to Lower cardiovascular events in addition to Aspirin with or without thienopyridine therapy in Subjects with Acute Coronary Syndrome–Thrombolysis In Myocardial Infarction 46 (ATLAS ACS-TIMI 46)